美股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

美国抗疫概念

1,587.65

+38.242.47%

涨家数：13

跌家数：6

平家数：- -

市盈率：- -

高：1,588.15

开：1,552.03

低：1,552.03

收：1,549.38

成交量：1.60亿

成交额：56.23亿

市值：1.30万亿

流通市值：1.28万亿

数据加载中...

巩固英股“第一大权重股”地位，医药巨头阿斯利康股价创新高

华尔街见闻

辉瑞中国李进晖：本土合作将继续要向更早的研发阶段延伸

每日经济新闻

强生周敏涛：不再只靠自己创新正全面融入中国创新生态

微博财经-财道工作室

全球“药王”价格冲击，药企高管白宫晕倒！减肥药市场博弈大变局！

FTC出手，诺和诺德出局：辉瑞100亿美元收购Metsera后股价双双下跌

MedTrend医趋势

阿斯利康股价再创新高涨超2%

每日经济新闻

强生创新制药启动“生命经纬计划”

三季净赚49亿美元！医药巨头辉瑞，100亿美元收购Metsera

BUZZ-Cogent Biosciences 启动 4 亿美元股票和可转换交易，股价翻了一番多

伊诺维奥制药：若优先审查请求获批，Ino-3107的潜在PDUFA日期在2026年中期

医疗保健市场动态综述

辉瑞斩获肥胖症药物“战利品”，特朗普政府提供助力

环球市场播报

吉利德科学首席财务官表示公司将继续积极开展业务发展，包括许可和并购

吉利德科学首席财务官表示医保改革对艾滋病业务影响约为9亿美元，整体业务影响达12亿美元

FDA批准Premarin（结合雌激素）的仿制药，以扩展更年期症状的治疗选择

Vir Biotechnology, Inc.盘中异动早盘快速上涨5.07%报5.39美元

雷克兰医疗工业盘中异动股价大涨5.43%报16.81美元

辉瑞首席执行官：预计公司将为Metsera支付全部或有价值权利款项。

京东健康与欧姆龙、雅培等全球医疗器械品牌深化合作共筑健康管理新生态

BUZZ-Cogent Biosciences 在试验中使用组合药物延缓癌症进展，业绩飙升

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/BK4568/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4568","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","market":"US","secType":"PLATE","nameCN":"美国抗疫概念","latestPrice":1587.6166,"timestamp":1762894055719,"preClose":1549.3801,"halted":0,"volume":160452845,"delay":0,"changeRate":0.024679,"floatShares":0,"shares":0,"eps":0,"marketStatus":"交易中","change":38.23645,"latestTime":"11-11 15:47:35 EST","open":1552.0281,"high":1588.146,"low":1552.0264,"amount":5623300901.703124,"amplitude":0.023312,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1762894800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":3.914839,"peRate":20.270666,"turnoverRate":0.010442,"increases":13,"decrements":6,"flats":0,"marketCap":1299354139386,"floatMarketCap":1278211570088},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","high":1588.146,"amplitude":0.023312,"preClose":1549.3801,"low":1552.0264,"pbRate":"3.914839","latestPrice":1587.6504,"volume":160473231,"delay":0,"open":1552.0281,"prevYearClose":1274.8187,"prevWeekClose":1534.8367,"prevMonthClose":1528.0375,"prevQuarterClose":1508.8958,"fiveDayClose":1526.5634,"twentyDayClose":1560.842,"sixtyDayClose":1491.7644,"secType":"PLATE","market":"US","turnoverRate":0.010444,"peRate":20.270666,"marketCap":1299229043838,"floatMarketCap":1278086514892,"timestamp":1762894057103,"nameCN":"美国抗疫概念"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4568\",,,,undefined,":{"bkCode":"BK4568","up":13,"down":6,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4568\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2582364262","title":"巩固英股“第一大权重股”地位，医药巨头阿斯利康股价创新高","url":"https://stock-news.laohu8.com/highlight/detail?id=2582364262","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582364262?lang=zh_cn&edition=fundamental","pubTime":"2025-11-11 21:49","pubTimestamp":1762868998,"startTime":"0","endTime":"0","summary":"11月11日，医药巨头阿斯利康英股股价一度涨至134.6英镑，创历史新高。作为富时100指数第一大权重股，其强势表现推动该指数同步上涨1.1%，亦创新高。股价上涨主要受前三季度营收与每股收益双位数增长的亮眼业绩支撑，此外美国药品定价协议缓解政策担忧，进一步提振市场信心。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":null,"url":"https://wallstreetcn.com/articles/3759137","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3759137","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","09939","LU2462157665.USD","LU1829250122.USD","LU0109394709.USD","LU2456880835.USD","LU0889565916.HKD","BK1161","BK1515","BK4007","BK1574","BK4588","LU0320765992.SGD","LU2236285917.USD","BK4568","LU2417539215.USD","AZN","159938"],"gpt_icon":0},{"id":"2582364740","title":"辉瑞中国李进晖：本土合作将继续 要向更早的研发阶段延伸","url":"https://stock-news.laohu8.com/highlight/detail?id=2582364740","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582364740?lang=zh_cn&edition=fundamental","pubTime":"2025-11-11 21:45","pubTimestamp":1762868723,"startTime":"0","endTime":"0","summary":"11月5日至10日，第八届中国国际进口博览会（以下简称进博会）在上海举行。辉瑞第七次参展，展示了包括在研的膀胱癌免疫抑制剂Sasanlimab、晚期前列腺癌EZH2抑制剂Mevrometostat等在内的肿瘤药物创新研发成果，还重点展出了血友病治疗领域的非因子创新疗法——马塔西单抗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202511113561260263.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202511113561260263.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["IE00BBT3K403.USD","LU0306806265.USD","LU0321505439.SGD","SG9999002232.USD","SG9999001176.SGD","BK4534","LU0234572021.USD","SG9999013999.USD","LU1066053197.SGD","BK4581","PFE","LU1883839398.USD","SG9999001176.USD","SG9999002224.SGD","LU0170899867.USD","BK4585","IE00B19Z3581.USD","LU1057294990.SGD","LU0306807586.USD","LU0225284248.USD","LU1023059063.AUD","IE00BLSP4452.SGD","BK4592","SG9999003800.SGD","BK4550","SGXZ57979304.SGD","LU0289739699.SGD","LU1894683264.USD","LU0321505868.SGD","LU0058720904.USD","IE000M9KFDE8.USD","LU0122379950.USD","SG9999011175.SGD","BK4007","LU0868494617.USD","IE00BLSP4239.USD","LU1894683348.USD","BK4533","BK4599","IE00B19Z3B42.SGD","LU0456855351.SGD","LU1066051498.USD","BK4588","IE0002270589.USD","LU0225771236.USD","BK4568","LU0985481810.HKD"],"gpt_icon":1},{"id":"2582499363","title":"强生周敏涛：不再只靠自己创新 正全面融入中国创新生态","url":"https://stock-news.laohu8.com/highlight/detail?id=2582499363","media":"微博财经-财道工作室","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582499363?lang=zh_cn&edition=fundamental","pubTime":"2025-11-11 18:59","pubTimestamp":1762858740,"startTime":"0","endTime":"0","summary":"2025年9月，在强生创投的领投下，瑞龙外科完成了6700万美元的D轮融资。2018年之后，强生做了多笔手术机器人资产收购，其中有数款产品获批上市。目前，强生只有一款手术机器人在华获批，即经自然腔道诊疗机器人MONARCH。周敏涛告诉经济观察报，强生对中国市场的态度一直非常坚定。据周敏涛介绍，强生在进博会上累计带来了1000余款产品。周敏涛认为，这意味着“我们正全面融入中国的创新生态，不再只靠自己的创新”。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/wbstock/2025-11-11/doc-infwzrrx4321568.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4504","LU2129689514.USD","LU1261432733.SGD","LU2089984988.USD","LU0912757837.SGD","LU2430703095.HKD","IE0034235303.USD","JNJ","LU2129689431.USD","LU2347655156.SGD","LU0640476718.USD","LU1057294990.SGD","LU0203347892.USD","LU1935042991.SGD","IE00BBT3K403.USD","LU0985320562.USD","BK4568","LU1032466523.USD","LU1280957306.USD","IE00BDGV0183.EUR","IE00BVYPNV92.GBP","LU0889566641.SGD","LU1061106388.HKD","LU0114720955.EUR","BK4007","IE00B4R5TH58.HKD","LU2592432038.USD","IE00BJT1NW94.SGD","IE00B1BXHZ80.USD","LU1032955483.USD","LU0466842654.USD","LU1066053197.SGD","IE00BFXG1179.USD","IE00B3T34201.USD","IE00BSNM7G36.USD","LU0122379950.USD","LU1894683348.USD","IE00BJJMRZ35.SGD","BK4585","LU1059921491.USD","IE0002270589.USD","IE00BLSP4239.USD","IE0002141913.USD","LU2129689605.HKD","LU1162221912.USD","BK4592","LU1196500208.SGD","LU1778281490.HKD","IE00BN8TJ469.HKD","LU1506573853.SGD"],"gpt_icon":0},{"id":"2582357704","title":"全球“药王”价格冲击，药企高管白宫晕倒！减肥药市场博弈大变局！","url":"https://stock-news.laohu8.com/highlight/detail?id=2582357704","media":"药经说","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582357704?lang=zh_cn&edition=fundamental","pubTime":"2025-11-11 17:30","pubTimestamp":1762853428,"startTime":"0","endTime":"0","summary":"日前，在华盛顿特区白宫椭圆形办公室内，一场改变全球重磅药物市场格局的谈判备受关注。新一轮“药王”争夺战这场“药王价格崩盘”事件，远非简单的商业谈判，而是美国医药产业大变局的缩影。2024年，全球GLP-1类药物总销售额突破500亿美元，其中减重适应症贡献140亿美元。阿斯利康承诺大幅降低美国市场的药品价格，以确保美国患者能够以与富裕国家相同的价格获得这些药品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251111174032a6f1ad8e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251111174032a6f1ad8e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BBT3K403.USD","LU0306806265.USD","LU0321505439.SGD","IE00BZ1G4Q59.USD","SG9999002232.USD","LU1093756168.USD","SG9999001176.SGD","BK4534","LU0234572021.USD","LU1066053197.SGD","BK4581","SG9999001176.USD","LU1883839398.USD","SG9999002224.SGD","LU0170899867.USD","LU1093756325.SGD","BK4585","IE00B19Z3581.USD","LU1057294990.SGD","BK4532","LU0306807586.USD","LU0225284248.USD","LU1023059063.AUD","IE00BLSP4452.SGD","SG9999003800.SGD","BK4550","SGXZ57979304.SGD","LU0289739699.SGD","LU1894683264.USD","LU0321505868.SGD","IE00BKVL7J92.USD","LU0058720904.USD","LU0122379950.USD","IE000M9KFDE8.USD","SG9999011175.SGD","BK4007","LU0868494617.USD","LU1894683348.USD","BK4533","BK4599","IE00B19Z3B42.SGD","LU0456855351.SGD","LU1066051498.USD","IE0002270589.USD","NVO","LU0225771236.USD","LU0154236417.USD","BK4568","LU0985481810.HKD"],"gpt_icon":1},{"id":"2582908350","title":"FTC出手，诺和诺德出局：辉瑞100亿美元收购Metsera后股价双双下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2582908350","media":"MedTrend医趋势","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582908350?lang=zh_cn&edition=fundamental","pubTime":"2025-11-11 17:04","pubTimestamp":1762851892,"startTime":"0","endTime":"0","summary":"路透社消息：11月8日，辉瑞以最高100亿美元的价格击败诺和诺德，成功拿下减肥药新星Metsera。此前，11月5日，FTC向诺和诺德发出警告信，指出其收购方案可能违反《哈特-斯科特-罗迪诺反垄断改进法》，并可能降低Metsera继续开发药物的动力。Metsera随后表示，诺和诺德的方案存在\"不可接受的高法律和监管风险\"。从9月22日宣布初步收购协议至今，辉瑞股价累计下跌约3.6%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251111183002a6f1c972&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251111183002a6f1c972&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0234572021.USD","LU1066053197.SGD","BK4599","BK4007","IE00BLSP4452.SGD","FTC","LU0122379950.USD","SG9999002232.USD","LU0225771236.USD","BK4585","LU0321505868.SGD","SG9999011175.SGD","LU0868494617.USD","IE0002270589.USD","LU0289739699.SGD","BK4139","BK4550","BK4568","LU1066051498.USD","IE00BBT3K403.USD","LU0058720904.USD","SG9999003800.SGD","NVO","MTSR","LU0170899867.USD","LU0985481810.HKD","IE00BKVL7J92.USD","IE00B19Z3B42.SGD","LU0154236417.USD","LU0456855351.SGD","SG9999002224.SGD","LU1023059063.AUD","LU1894683264.USD","LU1093756168.USD","SG9999001176.SGD","LU0225284248.USD","BK4534","IE00B19Z3581.USD","LU0306806265.USD","LU1093756325.SGD","PFE","IE00BZ1G4Q59.USD","LU0306807586.USD","BK4592","BK4532","BK4581","LU1883839398.USD","BK4588","IE00BLSP4239.USD","IE000M9KFDE8.USD"],"gpt_icon":1},{"id":"2582594303","title":"阿斯利康股价再创新高 涨超2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2582594303","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582594303?lang=zh_cn&edition=fundamental","pubTime":"2025-11-11 16:36","pubTimestamp":1762850202,"startTime":"0","endTime":"0","summary":"阿斯利康股价再创新高 涨超2%","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202511113561034662.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202511113561034662.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4588","AZN","LU0320765992.SGD","LU2417539215.USD","LU2236285917.USD","BK4007","LU0889565916.HKD","BK4568","BK4585","LU2462157665.USD","LU0109394709.USD","LU1829250122.USD","LU2456880835.USD"],"gpt_icon":0},{"id":"2582552503","title":"强生创新制药启动“生命经纬计划”","url":"https://stock-news.laohu8.com/highlight/detail?id=2582552503","media":"新京报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582552503?lang=zh_cn&edition=fundamental","pubTime":"2025-11-11 15:54","pubTimestamp":1762847680,"startTime":"0","endTime":"0","summary":"恰逢进入中国市场40周年，强生创新制药近日在北京举办的首届“端到端”患者健康管理峰会上，正式启动守护患者全周期健康的“生命经纬计划”，为中国患者编织一张全面、连贯的“生命经纬”守护网。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202511113560980576.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202511113560980576.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["IE000M9KFDE8.USD","LU1221951129.SGD","BK4568","LU0466842654.USD","IE00B2B36J28.USD","LU2750360997.AUD","LU1894683348.USD","LU1732799900.SGD","IE00B1BXHZ80.USD","LU1221951046.USD","IE0002141913.USD","LU1244550221.USD","LU1061106388.HKD","LU2468319806.SGD","LU2505996681.GBP","IE0002270589.USD","LU0114720955.EUR","LU0070217475.USD","LU0792757196.USD","LU1162221912.USD","LU2129689431.USD","LU1732800096.USD","LU0234572021.USD","IE00BLSP4239.USD","IE00BSNM7G36.USD","LU1280957306.USD","IE00BJJMRZ35.SGD","01477","IE0034235303.USD","LU0345769128.USD","LU0912757837.SGD","LU1496350502.SGD","IE0009355771.USD","LU0122379950.USD","LU2347655156.SGD","LU2471134879.HKD","LU0795875169.SGD","IE00BLSP4452.SGD","IE00BVYPNW00.USD","LU0640476718.USD","BK4592","BK4581","LU0345770993.USD","JNJ","IE00B3PB1722.GBP","LU2505996509.AUD","BK4533","IE00B4R5TH58.HKD","LU0345770308.USD","LU0203345920.USD"],"gpt_icon":0},{"id":"2582387897","title":"三季净赚49亿美元！医药巨头辉瑞，100亿美元收购Metsera","url":"https://stock-news.laohu8.com/highlight/detail?id=2582387897","media":"云掌财经","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582387897?lang=zh_cn&edition=fundamental","pubTime":"2025-11-11 08:38","pubTimestamp":1762821492,"startTime":"0","endTime":"0","summary":"11月18日，有消息称，辉瑞已同意以100亿美元收购减肥药研发初创企业Metsera，此前该公司与诺和诺德就后者展开激烈竞购。Metsera宣布，已与辉瑞达成修订版合并协议，辉瑞将以每股最高86.25美元收购Metsera，其中包括每股65.60美元的初始现金支付，以及达到特定里程碑时最高每股20.65美元的额外付款。加上辉瑞收购Metsera的搅局，诺和诺德未来受到的冲击将更加的明显。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511110838259761498e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511110838259761498e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","MTSR","BK4550","BK4533","LU0985481810.HKD","LU0321505439.SGD","LU0225284248.USD","IE00B19Z3581.USD","BK4568","IE00BLSP4239.USD","LU0868494617.USD","IE000M9KFDE8.USD","LU1883839398.USD","LU1894683348.USD","SG9999001176.SGD","BK4581","LU0456855351.SGD","BK4532","IE00B19Z3B42.SGD","IE00BBT3K403.USD","SG9999002224.SGD","LU1066053197.SGD","LU1093756325.SGD","LU0234572021.USD","BK4585","LU1066051498.USD","SG9999011175.SGD","LU0306807586.USD","SG9999003800.SGD","LU0321505868.SGD","IE0002270589.USD","LU0058720904.USD","LU0225771236.USD","NVO","BK4139","LU0154236417.USD","SG9999002232.USD","LU1057294990.SGD","SG9999001176.USD","SG9999013999.USD","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","LU0170899867.USD","LU1023059063.AUD","PFE","LU1894683264.USD","BK4588","LU1093756168.USD","BK4592","LU0306806265.USD"],"gpt_icon":1},{"id":"2582722385","title":"BUZZ-Cogent Biosciences 启动 4 亿美元股票和可转换交易，股价翻了一番多","url":"https://stock-news.laohu8.com/highlight/detail?id=2582722385","media":"路透中文","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582722385?lang=zh_cn&edition=fundamental","pubTime":"2025-11-11 06:21","pubTimestamp":1762813274,"startTime":"0","endTime":"0","summary":"** 在晚期试验中，COGT的药物bezuclastinib与辉瑞公司PFE.N的Sutent联用，减缓了胃癌 ，股价周一收盘上涨119%，创7年新高32.46美元。** 收盘后，该公司开始  同时公开发行 2 亿美元的可转换债券 2031 年到期，以及 2 亿美元的股票。摩根大通、杰富瑞、Leerink 和 Guggenheim 主导此次股权交易。** COGT 股价在收盘后下跌 0.3%，至 32.35 美元。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251110:nL4S3WM1RJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2264538146.SGD","BK4007","LU1057294990.SGD","LU0170899867.USD","IE00BFXG1179.USD","LU0211326755.USD","LU0787776722.HKD","LU2381873111.SGD","SG9999001176.USD","COGT","IE000M9KFDE8.USD","LU0306807586.USD","LU1668664300.SGD","LU1244550577.SGD","LU1548497426.USD","LU2552382132.HKD","IE00BWXC8680.SGD","IE00BKVL7J92.USD","BK4568","LU0943347566.SGD","BK4505","LU1720051108.HKD","BK4504","LU0683600562.USD","LU0321505868.SGD","LU0306806265.USD","LU0345769631.USD","LU1267930490.SGD","IE00BHPRN162.USD","LU1670627923.USD","BK4127","LU0006306889.USD","IE00BJTD4N35.SGD","LU2756315664.SGD","BK4207","BK4599","LU0234572021.USD","JEF","LU0208291251.USD","SGXZ57979304.SGD","LU0345769128.USD","LU1084165304.USD","LU0820562030.AUD","SG9999011175.SGD","BK4566","LU0211326839.USD","LU0345770993.USD","LU0345770308.USD","IE00BLSP4239.USD"],"gpt_icon":1},{"id":"1102265080","title":"伊诺维奥制药：若优先审查请求获批，Ino-3107的潜在PDUFA日期在2026年中期","url":"https://stock-news.laohu8.com/highlight/detail?id=1102265080","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1102265080?lang=zh_cn&edition=fundamental","pubTime":"2025-11-11 05:53","pubTimestamp":1762811589,"startTime":"0","endTime":"0","summary":"伊诺维奥制药：若优先审查请求获批，Ino-3107的潜在PDUFA日期在2026年中期","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INO","BK4568","BK4139","BK4583"],"gpt_icon":0},{"id":"1122731595","title":"医疗保健市场动态综述","url":"https://stock-news.laohu8.com/highlight/detail?id=1122731595","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1122731595?lang=zh_cn&edition=fundamental","pubTime":"2025-11-11 01:23","pubTimestamp":1762795420,"startTime":"0","endTime":"0","summary":"最新的市场动态涵盖医疗保健领域。于东部时间4:20、12:20和16:50独家发布。辉瑞需要扩大其药物管线，而此次交易表明了其在肥胖治疗市场中获得份额的决心。分析师萨西卡恩·乌德温在一份报告中表示，该医疗保健公司第三季度的收益创下223百万泰铢的纪录，受益于税收优惠和更高的收入。她预计，由于新病床的增加、流感暴发所带来的更多本地患者以及新的国际患者市场，集团的强劲收益势头将在第四季度继续。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0096374516.USD","LU0345776255.USD","IE00BLSP4239.USD","LU2257852520.SGD","LU1497733557.USD","LU0225284248.USD","LU0029875118.USD","LU1211504680.USD","LU0878004406.USD","LU0048573645.USD","BK4592","LU0345775950.USD","LU1956131251.USD","LU0122379950.USD","LU0577902538.SGD","SG9999002406.SGD","LU0261947096.USD","LU0588545904.SGD","LU0488056044.USD","SG9999001846.SGD","LU1504937902.USD","SG9999002224.SGD","LU0261945553.USD","SG9999007991.SGD","SG9999016042.SGD","SG9999013460.SGD","LU0441851309.USD","LU0823397103.USD","LU1732800096.USD","LU0235996351.USD","LU0306807586.USD","LU0543330483.HKD","LU1244550577.SGD","LU2023251221.USD","SGXZ24219693.SGD","LU0648948544.HKD","LU0289739699.SGD","LU1066053197.SGD","SG9999011175.SGD","SG9999013486.USD","LU0314104364.USD","LU2111349929.HKD","BK4568","LU0831093199.SGD","LU0225283273.USD","LU1057294990.SGD","LU0267386448.USD","LU0898667661.SGD","BK4581","SG9999005177.SGD","LU0532188223.SGD","LU0321505868.SGD","PFE","SG9999002562.SGD","LU0823417737.USD","LU0384037296.USD","BK6523","BK4533","LU0441854154.USD","LU0084288322.USD","LU0950375773.USD","LU0955623706.USD","LU1548497426.USD","LU0886674414.USD","IE00BLSP4452.SGD","BK6516","LU0048597586.USD","LU0251144936.SGD","IE0031814969.USD","LU0588545490.SGD","LU2506952170.USD","LU0234572021.USD","SG9999001176.USD","LU2089283258.USD","LU0762540952.USD","LU0882747503.HKD","LU1074936037.SGD","LU0577902611.USD","LU0320765646.SGD","LU1720051108.HKD","SG9999002414.USD","LU2271345857.HKD","LU1130305938.SGD","SG9999003826.SGD","LU0577902371.SGD","SG9999006266.SGD","LU0106261372.USD","LU0158827781.USD","SG9999000459.SGD","BK4516","LU0737861269.HKD","IE00BVYPNP33.GBP","LU0985481810.HKD","SGXZ27511609.SGD","LU0306806265.USD","LU1497733631.SGD","SG9999001135.SGD","SG9999008742.SGD","SGXZ58947870.SGD","BK4504","LU0882574139.USD","LU0955669360.SGD","LU1634259557.SGD","LU0128522157.USD","LU0823397285.USD","LU0795875086.SGD","SG9999004220.SGD","LU0170899867.USD","SG9999001127.SGD","LU0577902454.USD","BK4585","LU0061477393.USD","LU1770036033.HKD","LU1894683348.USD","LU2133065610.SGD","LU1363072403.SGD","D05.SI","SG9999002232.USD","LU2089284900.SGD","LU2347655156.SGD","LU1244550494.USD","BK4534","LU0868494617.USD","SG9999002620.SGD","LU0955648018.USD","LU1282649067.USD","BK4588","SG9999013999.USD","LU1732799900.SGD","LU1162221912.USD","IE00BKZH1Z71.USD","SG9999000475.SGD","LU0912757837.SGD","LU0326948709.USD","LU0795875169.SGD","LU0878005551.USD","BK4550","LU1634259391.SGD","LU1282649810.SGD","LU1522347837.USD","LU1497734951.SGD","LU1989772840.SGD","LU0106831901.USD","LU0205439572.USD","LU0158827948.USD","LU1668664300.SGD","LU1282649141.HKD","BK4007","IE00BVYPNQ40.USD","SGXZ43160589.SGD","LU0225771236.USD","LU1839390173.USD","LU0557290698.USD","LU1023059063.AUD","LU1894683264.USD","SG9999001176.SGD","LU0011963245.USD","LU0865486749.SGD","BK4139","LU2506952097.USD","LU0058720904.USD","BK6112","IE00BZ1G4Q59.USD","LU0210637038.USD","BK4599","LU0630378429.USD","SG9999013353.USD","LU2506951958.HKD","LU0456855351.SGD","LU0577902298.EUR","SG9999002679.SGD","SG9999001903.USD","IE000M9KFDE8.USD","IE00B19Z3581.USD","SGXZ57979304.SGD","LU0192582467.USD","LU2028103732.USD","MTSR","LU0971096721.USD","LU0098860793.USD","LU0006306889.USD","SG9999001226.SGD","LU1066051498.USD","BK4127","LU1720051017.SGD","SG9999004360.SGD","IE00B19Z3B42.SGD","LU0321505439.SGD","LU0831103253.SGD","SG9999014492.USD","LU0188438112.USD","LU0672654166.SGD","LU0873338254.USD","IE0002270589.USD","LU0588545730.USD","LU1244550221.USD","LU1989772923.USD","IE00BGHQDM52.EUR","LU0675040207.SGD","IE00BBT3K403.USD","SG9999000343.SGD","SG9999002604.SGD","LU0234570918.USD","SG9999003800.SGD","LU0823413660.USD","LU2357305700.SGD","SG9999014302.SGD","LU0315178854.USD","LU2238330802.EUR","LU2506951875.HKD","LU0823413587.USD","LU1883839398.USD","MS","LU0823417653.USD","SG9999013478.USD","IE00BKVL7J92.USD","LU0251143029.SGD","SG9999014484.SGD"],"gpt_icon":1},{"id":"2582805101","title":"辉瑞斩获肥胖症药物“战利品”，特朗普政府提供助力","url":"https://stock-news.laohu8.com/highlight/detail?id=2582805101","media":"环球市场播报","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582805101?lang=zh_cn&edition=fundamental","pubTime":"2025-11-11 00:46","pubTimestamp":1762793160,"startTime":"0","endTime":"0","summary":"长期以来，辉瑞公司首席执行官阿尔伯特布尔拉一直在寻找一款肥胖症药物，以弥补该制药公司旗下 “老款重磅药物” 销量下滑的缺口。上周五晚间，经过一场激烈的竞标战，他终于得偿所愿，拿下了这一 “战利品”。　　辉瑞随即采取行动。　　梅塞拉在声明中表示，美国政府的态度对其决策影响重大，并提及决策过程中考虑的法律与监管因素。出于这些顾虑，董事会决定与辉瑞协商敲定最终交易。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2025-11-11/doc-infwxxhn2551880.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["SG9999001176.USD","LU0456855351.SGD","BK4592","LU0225771236.USD","BK4007","LU0289739699.SGD","SG9999011175.SGD","SGXZ57979304.SGD","IE0002270589.USD","LU0234572021.USD","LU1057294990.SGD","BK4599","LU0225284248.USD","BK4534","LU0321505868.SGD","SG9999003800.SGD","IE00B19Z3B42.SGD","LU1066053197.SGD","IE00BLSP4452.SGD","LU0321505439.SGD","LU0868494617.USD","IE00BBT3K403.USD","BK4568","LU0306807586.USD","LU0122379950.USD","LU1066051498.USD","LU1883839398.USD","LU1894683348.USD","IE000M9KFDE8.USD","LU1023059063.AUD","LU1894683264.USD","BK4585","BK4581","SG9999002224.SGD","BK4588","BK4533","SG9999013999.USD","LU0306806265.USD","IE00B19Z3581.USD","SG9999002232.USD","LU0985481810.HKD","BK4550","PFE","LU0058720904.USD","IE00BLSP4239.USD","LU0170899867.USD","SG9999001176.SGD"],"gpt_icon":1},{"id":"1157913444","title":"吉利德科学首席财务官表示公司将继续积极开展业务发展，包括许可和并购","url":"https://stock-news.laohu8.com/highlight/detail?id=1157913444","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1157913444?lang=zh_cn&edition=fundamental","pubTime":"2025-11-11 00:35","pubTimestamp":1762792519,"startTime":"0","endTime":"0","summary":"吉利德科学首席财务官表示公司将继续积极开展业务发展，包括许可和并购。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0109394709.USD","BK4532","LU0289739699.SGD","LU2089984988.USD","LU2324357040.USD","IE00B19Z3581.USD","LU0058720904.USD","BK4588","BK4583","LU0823416689.USD","LU2087621335.USD","LU0234570918.USD","LU1839511570.USD","LU0114720955.EUR","LU1778281490.HKD","IE00B19Z3B42.SGD","BK4568","LU1585245621.USD","LU1066051498.USD","IE00BSNM7G36.USD","SG9999015945.SGD","SG9999015986.USD","LU1571399168.USD","LU1674673691.USD","LU2468319806.SGD","GILD","BK4585","LU1674673428.USD","SG9999015978.USD","BK4566","LU0882574055.USD","IE00B7SZLL34.SGD","IE00B3T34201.USD","BK4139","IE0002270589.USD","LU0889565916.HKD","LU1066053197.SGD","BK4550","IE00BKVL7J92.USD","BK4578","LU1430594728.SGD","SG9999015952.SGD","LU0320765992.SGD","IE00BZ1G4Q59.USD"],"gpt_icon":0},{"id":"1145102354","title":"吉利德科学首席财务官表示医保改革对艾滋病业务影响约为9亿美元，整体业务影响达12亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1145102354","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1145102354?lang=zh_cn&edition=fundamental","pubTime":"2025-11-11 00:13","pubTimestamp":1762791201,"startTime":"0","endTime":"0","summary":"吉利德科学首席财务官表示，医保改革对艾滋病业务的影响约为9亿美元，整体业务的影响则达到12亿美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765992.SGD","LU1571399168.USD","LU0109394709.USD","IE00B19Z3B42.SGD","LU2089984988.USD","LU0289739699.SGD","BK4588","LU1674673428.USD","LU0058720904.USD","SG9999015986.USD","BK4578","LU2087621335.USD","BK4568","IE00B7SZLL34.SGD","IE00BZ1G4Q59.USD","GILD","LU1430594728.SGD","BK4583","LU1585245621.USD","LU1674673691.USD","BK4550","LU0114720955.EUR","LU1066051498.USD","LU1839511570.USD","LU0234570918.USD","LU0882574055.USD","IE00BKVL7J92.USD","IE00B19Z3581.USD","LU1066053197.SGD","IE00B3T34201.USD","IE00BSNM7G36.USD","BK4585","SG9999015978.USD","BK4566","IE0002270589.USD","BK4139","LU2468319806.SGD","LU2324357040.USD","SG9999015945.SGD","SG9999015952.SGD","LU0823416689.USD","BK4532","LU0889565916.HKD","LU1778281490.HKD"],"gpt_icon":0},{"id":"1141444807","title":"FDA批准Premarin（结合雌激素）的仿制药，以扩展更年期症状的治疗选择","url":"https://stock-news.laohu8.com/highlight/detail?id=1141444807","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1141444807?lang=zh_cn&edition=fundamental","pubTime":"2025-11-11 00:11","pubTimestamp":1762791074,"startTime":"0","endTime":"0","summary":"FDA批准Premarin（结合雌激素）的仿制药，以扩展更年期症状的治疗选择","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0289739699.SGD","BK4550","SG9999003800.SGD","BK4581","SG9999013999.USD","BK4585","LU0321505439.SGD","LU1023059063.AUD","BK4533","LU0868494617.USD","LU0306806265.USD","SG9999001176.USD","LU1066053197.SGD","SG9999002224.SGD","BK4588","LU0225771236.USD","LU1883839398.USD","LU0122379950.USD","IE00BLSP4452.SGD","SG9999002232.USD","IE00BBT3K403.USD","BK4592","LU0985481810.HKD","BK4599","IE00B19Z3B42.SGD","LU0058720904.USD","SG9999001176.SGD","BK4534","IE00BLSP4239.USD","IE0002270589.USD","LU0225284248.USD","LU1894683264.USD","LU1066051498.USD","SG9999011175.SGD","LU0321505868.SGD","LU1057294990.SGD","IE00B19Z3581.USD","LU0234572021.USD","LU1894683348.USD","SGXZ57979304.SGD","LU0170899867.USD","BK4568","PFE","LU0306807586.USD","LU0456855351.SGD","BK4007","IE000M9KFDE8.USD"],"gpt_icon":0},{"id":"2582380579","title":"Vir Biotechnology, Inc.盘中异动 早盘快速上涨5.07%报5.39美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2582380579","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582380579?lang=zh_cn&edition=fundamental","pubTime":"2025-11-10 23:57","pubTimestamp":1762790255,"startTime":"0","endTime":"0","summary":"北京时间2025年11月10日23时57分，Vir Biotechnology, Inc.股票出现异动，股价急速拉升5.07%。截至发稿，该股报5.39美元/股，成交量31.5237万股，换手率0.23%，振幅3.12%。Vir Biotechnology, Inc.股票所在的生物技术行业中，整体涨幅为0.55%。Vir Biotechnology, Inc.公司简介：Vir Biotechnology Inc 是一家免疫学公司，专注于结合尖端技术治疗和预防严重传染病和其他严重疾病，包括病毒相关疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251110235735a6efe0fc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251110235735a6efe0fc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","BK4139","BK4535","VIR","BK4585"],"gpt_icon":0},{"id":"2582355476","title":"雷克兰医疗工业盘中异动 股价大涨5.43%报16.81美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2582355476","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582355476?lang=zh_cn&edition=fundamental","pubTime":"2025-11-10 22:39","pubTimestamp":1762785576,"startTime":"0","endTime":"0","summary":"北京时间2025年11月10日22时39分，雷克兰医疗工业股票出现波动，股价大幅拉升5.43%。截至发稿，该股报16.81美元/股，成交量1.1906万股，换手率0.12%，振幅2.95%。雷克兰医疗工业股票所在的服装制造行业中，整体涨幅为1.20%。其相关个股中，即亮集团、兰亭集势、雷克兰医疗工业涨幅较大，思宏国际、雷克兰医疗工业、安德玛-A较为活跃，换手率分别为0.26%、0.14%、0.13%，振幅较大的相关个股有思宏国际、雷克兰医疗工业、文斯控股，振幅分别为6.07%、4.74%、4.26%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251110223936976073e8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251110223936976073e8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00B19Z4B17.USD","IE00B7SZL793.SGD","LAKE","BK4568","IE0031619046.USD","BK4202","IE00B66KJ199.SGD"],"gpt_icon":0},{"id":"2582872084","title":"辉瑞首席执行官：预计公司将为Metsera支付全部或有价值权利款项。","url":"https://stock-news.laohu8.com/highlight/detail?id=2582872084","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582872084?lang=zh_cn&edition=fundamental","pubTime":"2025-11-10 22:21","pubTimestamp":1762784493,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU1894683348.USD","SG9999001176.SGD","SG9999011175.SGD","LU0234572021.USD","LU1023059063.AUD","BK4534","BK4592","SG9999001176.USD","LU0985481810.HKD","BK4007","LU0321505439.SGD","LU0170899867.USD","LU0058720904.USD","BK4599","LU0289739699.SGD","MTSR","LU1066053197.SGD","BK4550","LU1057294990.SGD","IE0002270589.USD","IE00B19Z3B42.SGD","SG9999002232.USD","IE00BLSP4452.SGD","LU0868494617.USD","BK4533","SG9999002224.SGD","BK4585","LU0306807586.USD","BK4568","LU1066051498.USD","BK4139","LU0456855351.SGD","SG9999003800.SGD","LU0122379950.USD","IE000M9KFDE8.USD","LU0306806265.USD","LU0225284248.USD","BK4581","SG9999013999.USD","SGXZ57979304.SGD","PFE","LU1883839398.USD","LU0225771236.USD","LU0321505868.SGD","IE00BBT3K403.USD","LU1894683264.USD","IE00B19Z3581.USD","BK4588","IE00BLSP4239.USD"],"gpt_icon":0},{"id":"2582387492","title":"京东健康与欧姆龙、雅培等全球医疗器械品牌深化合作 共筑健康管理新生态","url":"https://stock-news.laohu8.com/highlight/detail?id=2582387492","media":"证券日报","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582387492?lang=zh_cn&edition=fundamental","pubTime":"2025-11-10 21:36","pubTimestamp":1762781795,"startTime":"0","endTime":"0","summary":"本报讯（记者袁传玺）11月7日，在第八届中国国际进口博览会（以下简称“进博会”）期间，京东健康与欧姆龙健康医疗、雅培等全球多家医疗器械企业达成多项重要合作，在智能硬件设备打通、健康数据互联，以及慢病长周期管理等领域全面深化合作，加速构建“硬件-软件-服务-生态”四位一体的智能健康管理新生态。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202511103560024360.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU0882574055.USD","BK4533","BK4566","LU0266013472.USD","LU2468319806.SGD","SG9999004303.SGD","IE00B4R5TH58.HKD","LU0868494617.USD","IE00BFTCPJ56.SGD","86618","BK4588","BK1515","LU1061106388.HKD","06618","BK1222","BK1615","BK4592","IE0009355771.USD","09997","BK1589","LU0122379950.USD","LU0234572021.USD","BK4082","LU2211815571.USD","IE00B2B36J28.USD","LU1721429402.USD","LU2237957811.SGD","ABT","IE00BJJMRZ35.SGD","BK1591","LU1023059063.AUD","09996","BK1583","LU0289739699.SGD","BK4504","LU0058720904.USD","LU1721429741.USD","BK4568","LU0114720955.EUR","BK1571","BK1100","BK1574","LU1057294990.SGD","LU0051755006.USD","BK4581","BK4585","BK1247","LU2133065610.SGD","LU2324357040.USD","IE00BJT1NW94.SGD"],"gpt_icon":0},{"id":"2582871332","title":"BUZZ-Cogent Biosciences 在试验中使用组合药物延缓癌症进展，业绩飙升","url":"https://stock-news.laohu8.com/highlight/detail?id=2582871332","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582871332?lang=zh_cn&edition=fundamental","pubTime":"2025-11-10 21:11","pubTimestamp":1762780295,"startTime":"0","endTime":"0","summary":"BUZZ-Cogent Biosciences 在试验中使用组合药物延缓癌症进展，业绩飙升11月10日 - ** 药物开发商科景生物COGT.O股价盘前上涨128%至33.25美元** 该公司称，在一项晚期研究中，其试验性复合药物明显延缓了晚期胃癌患者的病情进展** COGT对胃肠道间质瘤患者进行了贝珠司替尼与辉瑞PFE.NSutent联合用药的测试，这些患者对标准一线治疗药物伊马替尼已无反应或不能耐受伊马替尼。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251110:nL4S3WM10N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0058720904.USD","LU0225771236.USD","SG9999001176.USD","BK4533","BK4581","IE00BLSP4452.SGD","LU1894683264.USD","LU1057294990.SGD","LU0122379950.USD","LU0289739699.SGD","LU1066053197.SGD","BK4139","LU0868494617.USD","COGT","BK4568","LU0170899867.USD","LU0321505439.SGD","SG9999002224.SGD","BK4585","LU1894683348.USD","LU0306806265.USD","SG9999002232.USD","SGXZ57979304.SGD","LU1066051498.USD","BK4007","SG9999003800.SGD","LU0306807586.USD","IE00B19Z3581.USD","LU0234572021.USD","LU0321505868.SGD","BK4505","IE00BLSP4239.USD","IE00BBT3K403.USD","SG9999011175.SGD","BK4534","BK4599","IE0002270589.USD","IE00B19Z3B42.SGD","LU1883839398.USD","SG9999013999.USD","LU1023059063.AUD","BK4588","LU0985481810.HKD","LU0225284248.USD","IE000M9KFDE8.USD","BK4550","BK4592","LU0456855351.SGD","SG9999001176.SGD"],"gpt_icon":1}],"pageSize":20,"totalPage":14,"pageCount":1,"totalSize":264,"code":"91000000","status":"200"}]}}